[go: up one dir, main page]

AU2002368154A1 - Improved synthesis for hydroxyalkylated heterocyclic bases - Google Patents

Improved synthesis for hydroxyalkylated heterocyclic bases

Info

Publication number
AU2002368154A1
AU2002368154A1 AU2002368154A AU2002368154A AU2002368154A1 AU 2002368154 A1 AU2002368154 A1 AU 2002368154A1 AU 2002368154 A AU2002368154 A AU 2002368154A AU 2002368154 A AU2002368154 A AU 2002368154A AU 2002368154 A1 AU2002368154 A1 AU 2002368154A1
Authority
AU
Australia
Prior art keywords
hydroxyalkylated
heterocyclic bases
improved synthesis
synthesis
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368154A
Inventor
Haoyun An
Jean-Luc Girardet
Zhi Hong
Robert Orr
Kanda Ramasamy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Research and Development
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of AU2002368154A1 publication Critical patent/AU2002368154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2002368154A 2002-08-08 2002-08-08 Improved synthesis for hydroxyalkylated heterocyclic bases Abandoned AU2002368154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/025540 WO2004014912A1 (en) 2002-08-08 2002-08-08 Improved synthesis for hydroxyalkylated heterocyclic bases

Publications (1)

Publication Number Publication Date
AU2002368154A1 true AU2002368154A1 (en) 2004-02-25

Family

ID=31713795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368154A Abandoned AU2002368154A1 (en) 2002-08-08 2002-08-08 Improved synthesis for hydroxyalkylated heterocyclic bases

Country Status (2)

Country Link
AU (1) AU2002368154A1 (en)
WO (1) WO2004014912A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
CA2573185A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
PH12015501678B1 (en) 2009-06-17 2022-07-06 Vertex Pharma Inhibitors of influenza viruses replication
AU2011343642A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (en) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед INFLUENCES OF INFLUENZA VIRUS REPLICATION
JP6615755B2 (en) 2013-11-13 2019-12-04 バーテックス ファーマシューティカルズ インコーポレイテッド Inhibitors of influenza virus replication
AU2014348752C1 (en) 2013-11-13 2019-11-21 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP6704416B2 (en) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Methods for preparing inhibitors of influenza virus replication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935946A (en) * 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
JP3675274B2 (en) * 2000-01-27 2005-07-27 ダイソー株式会社 Method for producing 9- (2-hydroxyalkyl) purine derivative and 1- (2-hydroxyalkyl) pyrimidine derivative

Also Published As

Publication number Publication date
WO2004014912A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2003255492A1 (en) Heterocyclic derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003262023A1 (en) Five-membered heterocyclic compounds
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
AU2003211424A1 (en) Nitrogen-containing heterocyclic compound
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
AU2003264386A1 (en) 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
AU2003278369A1 (en) 3-cyano-quinoline derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2002368154A1 (en) Improved synthesis for hydroxyalkylated heterocyclic bases
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003902882A0 (en) Piperidyl derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003221050A1 (en) Remedy for hypermyotonia
AU2003220825A1 (en) Remedy for glioblastoma
AU2003280578A1 (en) Heterocyclic compounds
AU2003231370A1 (en) Amide derivatives
AU2003250151A1 (en) Method for the synthesis of anthracycline-peptide conjugates
AU2003289222A1 (en) Benzomorpholine derivatives
AU2003235889A1 (en) Amide derivatives
AU2003238180A1 (en) 2-naphtamide derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase